Get started
Author

Shrinjaya B Thapa

Observed names: Shrin Thapa, Shrinjaya B. Thapa, Shrinjaya Thapa
ORCID: 0009-0006-1202-9064
Observed ORCID: 0009-0006-1202-9064
OpenAlex ID: A5071309028
Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19
2020 · Shrinjaya B. Thapa, Tanya S. Kakar, et al. · JAMA Internal Medicine · 92
PDF
Direct Oral Anticoagulants in Budd‐Chiari Syndrome
2024 · Shrinjaya B. Thapa, Gabriel Roman Souza, et al. · European Journal Of Haematology · 7
PDF
Adult Xp11.2 translocation renal cell carcinoma managed effectively with pazopanib
2021 · Cristian Solano, Shrinjaya Thapa, et al. · BMJ Case Reports · 4
Single Center Real World Experience of Talquetamab in Patients with Relapsed and Refractory Multiple Myeloma
2024 · Ariel F. Grajales-Cruz, Allison Graeter, et al. · Blood · 3
PDF
Problematic Proteins: A Patient with a High Paraprotein Concentration
2024 · Glen L Hortin, Robert T Stapp, et al. · Clinical Chemistry · 3
PDF
Safety and Efficacy of Standard of Care (SOC) Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM), a Single Center Experience
2024 · Ariel F. Grajales-Cruz, Doris K. Hansen, et al. · Blood · 2
Activity and Safety of Venetoclax (VEN)-Based Treatment in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (R/R MM)
2024 · Filip Ionescu, Shrinjaya B Thapa, et al. · Blood · 1
PDF
Heparin-Induced Thrombocytopenia (HIT)
2024 · Shrinjaya Thapa, Akriti G. Jain, et al. · Springer eBooks · 1
Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis
2023 · Yazeed Sawalha, Shayna R Sarosiek, et al. · Blood · 1
Impact of P16 Positivity on Clinical Outcomes in Nasopharyngeal Carcinoma: A Single Institution Study
2023 · Bipin Ghimire, Emma Trentacosta, et al. · Cureus · 1
PDF
Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)
2022 · Bipin Ghimire, Ashbita Pokharel, et al. · Clinical Lung Cancer · 1
A Case of Syncope Due to Intracardiac Leiomyomatosis
2022 · Shrinjaya Thapa, Bipin Ghimire, et al. · Cureus · 1
PDF
Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy
2026 · Christina I. Shincovich, Api Chewcharat, et al. · American Journal of Hematology
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma
2026 · Praneeth Reddy Sudalagunta, Filip Ionescu, et al. · medRxiv
Evolution of t(11;14) biology in multiple myeloma and it's role on outcomes to venetoclax treatment
2025 · Praneeth Reddy Sudalagunta, Filip Ionescu, et al. · Blood
PDF
Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis
2024 · Muhammad Junaid Tariq, Kristopher Attwood, et al. · Blood
PDF
Clinical Characteristics and Outcomes of Patients with MYD88 Positive Waldenström Macroglobulinemia: A Single Center Retrospective Analysis
2024 · Shrinjaya B Thapa, David Kaldas, et al. · Blood
The Natural History of Asymptomatic (Smoldering) Waldenström Macroglobulinemia (WM): Factors Predicting Progression to Symptomatic WM and Transformation
2024 · David Kaldas, Shrin Thapa, et al. · Clinical Lymphoma Myeloma & Leukemia
IBCL-666 The Natural History of Asymptomatic (Smoldering) Waldenström Macroglobulinemia (WM): Factors Predicting Progression to Symptomatic WM and Transformation
2024 · David Kaldas, Shrin Thapa, et al. · Clinical Lymphoma Myeloma & Leukemia
Gender disparities in Waldenstrom macroglobulinemia: Insights from a comprehensive analysis.
2024 · David Kaldas, Shrinjaya Thapa, et al. · Journal of Clinical Oncology
Impact of EBV positivity on clinical outcomes in nasopharyngeal cancer.
2023 · Bipin Ghimire, Ujjwal Karki, et al. · Journal of Clinical Oncology
Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience.
2023 · Filip Ionescu, Parth Patel, et al. · Journal of Clinical Oncology
Works count: 22
Citation count: 117
H-index: 3
I10-index: 1
Year
Topic
Type